Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ABOS

Acumen Pharmaceuticals, Inc.

CIK 0001576885 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$2.70
↓ 0.03 (-1.10%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$195.01M
P/E Ratio
-1.72
EPS
-2.00
Dividend Yield
Not covered
52W Position
63%
Beta
1.85

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.23
P/S
Not covered
EV/Revenue
Not covered
ROE
-129.5%
Valuation data covers 8,494/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 63%
$1.19$3.60

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$121.33M
Total Assets
$122.83M
Free Cash Flow
–

Recent news